Reply
Jose T. Altamirano, Javier Michelena, Ramon Bataller – 28 April 2016
Coagulation parameters and major bleeding in critically ill patients with cirrhosis
Andreas Drolz, Thomas Horvatits, Kevin Roedl, Karoline Rutter, Katharina Staufer, Nikolaus Kneidinger, Ulrike Holzinger, Christian Zauner, Peter Schellongowski, Gottfried Heinz, Thomas Perkmann, Stefan Kluge, Michael Trauner, Valentin Fuhrmann – 28 April 2016 – Disturbances of coagulation and hemostasis are common in patients with liver cirrhosis. The typical laboratory pattern mimics disseminated intravascular coagulation (DIC).
Assessing endotoxemia in alcoholic hepatitis
Tetsuji Fujita – 28 April 2016
Cryptogenic cirrhosis: Current knowledge and future directions
Alex Mercado‐Irizarry, Esther A. Torres – 27 April 2016
Transjugular intrahepatic portosystemic shunt for refractory ascites in patients with high model for end‐stage liver disease scores
Kavish R. Patidar, Arun J. Sanyal – 27 April 2016
The liver in systemic disease: Sepsis and critical illness
William Bernal – 27 April 2016
Polymorphisms in STAT4 are not associated with treatment response and spontaneous clearance of hepatitis C virus in europeans
Anastasia Asimakopoulos, Alessandra Mangia, Gregory J. Dore, Andrew R. Lloyd, Jacob George, Mohammed Eslam – 27 April 2016
Finding a new role for NEMO: A key player in preventing hepatocyte apoptosis and liver tumorigenesis by inhibiting RIPK1
I‐Fang Hsin, Erica Montano, Ekihiro Seki – 27 April 2016
Distinguishing immunoglobulin G4–related disease from its pancreatobiliary mimics: Are we there now?
James H. Tabibian, Keith D. Lindor – 27 April 2016
Granulomas of the liver
Emma L. Culver, Jennifer Watkins, Rachel H. Westbrook – 27 April 2016